Magnesium sulfate for prevention of preterm birth.

نویسندگان

  • Dean A Seehusen
  • Scott P Grogan
چکیده

Practice Pointers Preterm birth, defined as occurring before 37 weeks of gestation, is the leading cause of neonatal death and is associated with several shortand long-term infant morbidities. Tocolytics, agents that inhibit uterine contractions, are commonly used to prevent or delay preterm birth. Magnesium sulfate is one of the most commonly used tocolytics in the United States.1 An earlier pooled analysis of five trials involving 6,145 infants with similar inclusion criteria found a statistically significant benefit of magnesium sulfate as a neuroprotective agent (relative risk [RR] = 0.68; 95% confidence interval [CI], 0.54 to 0.87; number needed to treat = 63).2 This review included 37 studies, with a total of 3,571 women, in which magnesium sulfate was compared with no treatment, placebo, or one of several alternative tocolytic agents. Studies varied with respect to the gestational ages included (less than 30 weeks to up to 37 weeks), loading dosage of magnesium sulfate (4 to 8 g per hour), and maintenance dosage (1 to 6 g per hour). Primary outcomes included birth within 48 hours of trial entry, serious maternal outcomes, and serious infant outcomes, including death. Secondary outcomes included maternal adverse drug reactions and infant admission to the neonatal intensive care unit. Delivery within 48 hours of magnesium sulfate administration was reported in 19 trials that included 1,913 women. There were no significant differences in the risk of birth within 48 hours between women who received magnesium sulfate and those who received no medication, placebo, or any other tocolytic agent. The exact RR varied depending on the comparison agent, but none were statistically significant. Serious infant outcomes, defined as death, chronic lung disease, grade III-IV intraventricular hemorrhage or periventricular leukomalacia, or major neurosensory disability, were reported in 18 trials. None of these reached statistical significance. Magnesium sulfate administration also did not have significant effects on any less serious neonatal morbidities studied, including five-minute Apgar score of less than 7, respiratory distress syndrome, need for assisted ventilation, or necrotizing enterocolitis. When analyzed individually, the risks of death for fetuses, neonates, and infants were not significantly increased in those whose mothers were given magnesium sulfate vs. placebo. In the same regard, magnesium sulfate did not increase the risk of death for fetuses, neonates, and infants when compared with other tocolytic agents.3 However, when analyzed as an aggregate, the risk was increased (RR = 4.56; 95% CI, 1.00 to 20.86). It should be noted that these data are driven by the outcomes of one study of 167 patients, in which all the deaths occurred. Seven trials that included 930 women evaluated serious maternal outcomes, defined as death, cardiac arrest, respiratory arrest, or admission to an intensive care unit. None of these outcomes were reported in any of the seven trials. These are summaries of reviews from the Cochrane Library.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Postnatal Preventive Effect of Magnesium Sulfate on Intraventricular Hemorrhage of Preterm Infants

Background: Germinal matrix hemorrhage and intraventricular hemorrhage (GMH-IVH) are among the causes of morbidity and mortality in very low birth weight (VLBW) neonates. The aim of this study was to determine the postnatal prophylactic effect of magnesium sulfate on GMH-IVH.Methods: In this double-blind clinical trial, 140 VLBW newborns were selected. The babies with birth weight ≤ 1500 ...

متن کامل

Human chorionic gonadotropin (hCG) versus magnesium sulfate to arrest preterm

Introduction: Considering the high incidence of preterm labor and its known complications, and that human myometrium contains receptors for human chronic gonadotropin (hCG) and that hCG can inhibit myometrial contractions on vitro, made me study treating effects of hCG on preterm labor. This clinical trial study was carried out to compare the effect of hCG, and magnesium sulfate (mgso4) on pre...

متن کامل

Magnesium Sulfat Versus Placebo in Preterm Delivery Prevention

Abstract Preterm delivery is an important problem in gynecology and neonatology. To compare magnesium sulfat (Injection) and placebo effects in prevention of preterm delivery, in a Clinical trial, 13 women in treatment group and 19 women in control group were participated. Magnesium Sulfate (according to Protocol) and Ringer Solution or 2/3 Dextrose, 1/3 Salin Solution was given to treatment g...

متن کامل

Comparison of the Eficacy of Intravenous Magnesium Sulfate and Oral Indomethcin in the Management of Preterm Labor

Background & Aims: Preterm labor is often resulted in preterm births and increased rate of neonatal morbidity and mortality. Treatment consists of bedrest, hydration, pharmacologic interventions, and combinations of these. The purpose of this study was to compare the efficacy of intravenous magnesium sulfate (MgSO4) and indomethacin in the treatment of preterm labor pains. Neonatal and maternal...

متن کامل

Antenatal magnesium sulfate for neuroprotection before preterm birth?

Preterm infants are at increased risk for serious, lifelong neurologic abnormalities such as cerebral palsy.1,2 As the survival of preterm infants has improved with advances in perinatal care,2 the occurrence of cerebral palsy has increased further, since infants who would previously have died now survive with their cerebral pathology. Currently, more than 30% of children with cerebral palsy ar...

متن کامل

Neonatal effects of magnesium sulfate given to the mother.

OBJECTIVE Magnesium historically has been used for treatment and/or prevention of eclampsia or preterm labor. More recently, antepartum magnesium sulfate has been suggested for prevention of cerebral palsy in preterm infants. Although adverse effects and toxicity of magnesium in pregnant women are well known, the fetal-neonatal effects of magnesium are less clear. The objective of this study wa...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • American family physician

دوره 91 7  شماره 

صفحات  -

تاریخ انتشار 2015